Janssen Korea, as Korea operation of the pharmaceutical company of Johnson & Johnson, started as a joint company with the Yuhan Corporation in 1983. For the last 30 years, we have been committed to delivering innovative treatments for serious unmet medical needs, across the following five therapeutic areas: Cardiovascular and Metabolism, Neuroscience, Immunology, Oncology and hematology, and Infectious Diseases and Vaccines. Janssen Korea prepared a production based facility building, a factory in Hwaseong, Gyeonggi-do, in 1983. Hyangnam factory has grown into the base factory of Janssen in the Asia-Pacific region through production innovation and was promoted to be the production base factory of the pharmaceutical division of Johnson & Johnson, included in GPSG (Global Pharmaceutical Supply Group), in January 2009. The factory is exporting complete products to 8 Asian countries, Taiwan, HongKong, Vietnam, The Philippines, Thailand, Malaysia, Singapore and Indonesia.